WASHINGTON, D.C.—Sanjit Jolly, MD, lead investigator of the RIVAL trial, presented a case during the Cardiovascular Research Technologies (CRT) annual meeting Feb. 24 that radial access should be the preferred approach when operators treat female patients. However, a large randomized trial is assessing that exact question.
About the presenter:
Jolly is an interventional cardiologist at Hamilton Health Sciences and assistant professor at McMaster University in Hamilton, Ontario. He has formal training in clinical trials with a MSc in health research methodology from McMaster University.